| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP1033134B1 Compositions inhibiting smooth muscle proliferation and method for the diagnosis of arteriosclerosis |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953973A Preparation of candesartan cilexetil in high purity |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951919A Milrinone salt preparation method and its uses |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951493A Chinese medicinal preparation for treating apoplexy sequelae |
| 04/25/2007 | CN1951490A Lung beneficial preparation with astragalus root and scutellaria root for treating chronic pulmonary heart disease and preparation method thereof |
| 04/25/2007 | CN1951482A Chinese medicinal preparation for treating apoplexy sequelae |
| 04/25/2007 | CN1951481A Medicament for treating cerebral thrombosis |
| 04/25/2007 | CN1951474A A Chinese medicinal injection and preparation method thereof |
| 04/25/2007 | CN1951473A Quality control method of a Chinese medicinal injection |
| 04/25/2007 | CN1951469A Pharmaceutical composition for treating heart failure |
| 04/25/2007 | CN1951456A 'Jiang Ya Shu Mai' pills for preventing and treating arteriosclerosis |
| 04/25/2007 | CN1951453A Chinese medicinal granule for treating piles and preparation method thereof |
| 04/25/2007 | CN1951442A Chinese herbal medicament for treating piles |
| 04/25/2007 | CN1951435A Pills having blood pressure lowering and vessel relaxing functions |
| 04/25/2007 | CN1951432A Gingseng and aconite composition, its preparation, preparation process and usage |
| 04/25/2007 | CN1951431A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951429A Preparation process of corydalis rhizome extract and novel usage thereof |
| 04/25/2007 | CN1951427A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951426A Quality control method of a compound Chinese medicinal preparation |
| 04/25/2007 | CN1951421A Pharmaceutical composition for resisting apoplexy and sequelae thereof and preparation process and preparation thereof |
| 04/25/2007 | CN1951417A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951416A Quality control method of a compound Chinese medicinal preparation |
| 04/25/2007 | CN1951414A Compound Chinese medicinal preparation for promoting angiogenesis |
| 04/25/2007 | CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng |
| 04/25/2007 | CN1951406A Drop pills for treating coronary heart disease, angina pectoris and preparation method thereof |
| 04/25/2007 | CN1951404A Oral microemulsion of gingko leaf and preparation method thereof |
| 04/25/2007 | CN1951393A Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof |
| 04/25/2007 | CN1951385A Minipills containing simvastatin and derivative thereof and method for preparing formulation thereof |
| 04/25/2007 | CN1951384A Pharmaceutical composition for treating cerebrovascular diseases and preparation method thereof |
| 04/25/2007 | CN1951373A Method for preparing nimodipine dispersible tablet with high dissolution |
| 04/25/2007 | CN1951372A Solid oral dosage forms comprising valsartan and HCTZ |
| 04/25/2007 | CN1951228A A replenishing drink |
| 04/25/2007 | CN1312178C High density lipoprotein-reactive peptides |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312152C New purine derivatives |
| 04/25/2007 | CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 04/25/2007 | CN1312140C Lipid lowering biphenylcarboxamides |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1312116C Calcium acceptor active compound |
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311820C Compsn. of medication of containing ketone ester of gingkgo and general salviol acid and its use |
| 04/25/2007 | CN1311811C Granular powder for treating angina pectoris and its quality control method |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208596 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 04/24/2007 | US7208594 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds, |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/24/2007 | US7208522 Methods and compositions for the prevention and treatment of Syndrome X |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208508 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 04/24/2007 | US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208496 Substituted heterocyclic compounds |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208300 Enzymatic polypetide for use in the treatment of aneurysms and artheroslerosis |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208180 Oral administration of a preparation having a) long chain polyunsaturated fatty acids, and b) specified phospholipids, and c) compounds that factor in methionine metabolism, such as folate, B vitamins, magnesium and zinc |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2288722C Method of treating isolated systolic hypertension |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2281471C Process for preparing eprosartan |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/24/2007 | CA2171934C Endothelin receptor antagonists |
| 04/20/2007 | CA2562249A1 Anf analogue |
| 04/19/2007 | WO2007044910A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 04/19/2007 | WO2007044574A2 Pharmaceutical compositions, methods of preparation thereof, and methods of treatment |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043305A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043302A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007042776A1 Modulators of the purinergic signalling pathway for treating sodium homeostatsis, hypertension and aldosteronism |
| 04/19/2007 | WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1 |
| 04/19/2007 | WO2007042657A1 $g(d)d crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/19/2007 | WO2007042656A1 Delta crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/19/2007 | WO2007042467A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 04/19/2007 | WO2007042166A2 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 04/19/2007 | WO2007041868A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007017758A3 Novel cysteine protease inhibitors and their therapeutic applications |
| 04/19/2007 | WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 04/19/2007 | WO2007006391A3 Cynara scolymus extracts, the use thereof ans formulations containing them |
| 04/19/2007 | WO2006109170A3 Combination therapy for treatment of cardiovascular diseases and related conditions |
| 04/19/2007 | WO2006091775A3 Tropoelastin for promoting endothelial cell adhesion or migration |